Latest News for: hla-dq2

Edit

Celiac Disease Market to Witness Growth by 2034, asserts DelveInsight | Takeda, ImmunogenX, Precigen ActoBio, ...

GetNews 02 Dec 2024
"Celiac Disease Market" ... The pathogenesis of celiac disease involves a complex interaction between genetic factors, notably the HLA-DQ2 and HLA-DQ8 haplotypes, and environmental triggers such as viral infections and changes in the gut microbiota ... 1 ... 2.
Edit

Type 1 Diabetes Market Report 2032:- Latest FDA, EMA, PDMA, Pipeline Therapies, Epidemiology

GetNews 11 Jun 2024
... Evaluate the Efficacy and Safety of Diamyd® to Preserve Endogenous Beta Cell Function in Adolescents and Adults With Recently Diagnosed Type 1 Diabetes, Carrying the Genetic HLA DR3-DQ2 Haplotype.
Edit

preDQ – a software tool for peptide binding prediction to HLA‐DQ2 and HLA‐DQ8 (EFSA - European Food Safety Authority)

Public Technologies 10 Jul 2023
preDQ is a software tool for peptide binding prediction to HLADQ2 and HLA‐DQ8 proteins specially designed and developed for the European Food Safety Authority ... to HLA‐DQ2 and HLA‐DQ8 proteins.
Edit

What Is Celiac Disease?

Daily Times Chronicle 14 Jun 2023
You'll also learn more about the celiac disease diet, especially foods to eat and those to avoid ... Genetic testing for human leukocyte antigens (HLA-DQ2 and HLA DQ8) can be used to rule out celiac disease, according to the Mayo Clinic ... .
Edit

Equillium Announces Initiation of Phase 1 study of EQ102, A First-in-Class Multi-Cytokine Inhibitor of IL-15 and IL-21 Targeting Celiac Disease

Pharmiweb 02 Nov 2022
LA JOLLA, Calif.--(BUSINESS WIRE)--$EQ #celiac--Equillium, Inc. (Nasdaq ... About Celiac Disease ... It occurs selectively in individuals expressing human leukocyte antigen (HLA)-DQ2 or HLA-DQ8, and results in a mucosal inflammatory response in the intestine.
Edit

Equillium Announces Initiation of Phase 1 study of EQ102, A First-in-Class Multi-Cytokine Inhibitor of IL-15 ...

Eagle-Tribune 02 Nov 2022
LA JOLLA, Calif.--(BUSINESS WIRE)--Nov 2, 2022--. Equillium, Inc. (Nasdaq ... It occurs selectively in individuals expressing human leukocyte antigen (HLA)-DQ2 or HLA-DQ8, and results in a mucosal inflammatory response in the intestine ... EQ101 & EQ102 ... .
Edit

NIMA Partners and empowerDX, a division of Eurofins, Announce Strategic Partnership to Promote New Celiac ...

Longview News-Journal 15 Sep 2022
Easy, Take-at-Home Test, Identifies HLA Genetic Risk Factors for Celiac Disease with >99% Accuracy ... The Celiac Gene Risk Test, from empowerDX, measures three HLA gene markers (HLA-DQ2 + HLA-DQ8 + DQA1*05) using two simple mouth swabs.
  • 1

Most Viewed

×